5,0
30. Juni 2024
Aktueller Mitarbeiter
San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
It's inspiring to see our innovations, especially the SYNTAX Platform, used in cutting-edge genomics and personalized medicine research. It’s also a great place to grow professionally.
Kontras
More training, please . .